These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23824692)

  • 1. Polymorphisms of Helicobacter pylori signaling pathway genes and gastric cancer risk in the European Prospective Investigation into Cancer-Eurgast cohort.
    Companioni O; Bonet C; Muñoz X; Weiderpass E; Panico S; Tumino R; Palli D; Agnoli C; Vineis P; Boutron-Ruault MC; Racine A; Clavel-Chapelon F; Travis RC; Khaw KT; Riboli E; Murphy N; Vergnaud AC; Trichopoulou A; Benetou V; Trichopoulos D; Lund E; Johansen D; Lindkvist B; Johansson M; Sund M; Ardanaz E; Sánchez-Cantalejo E; Huerta JM; Dorronsoro M; Ramón Quirós J; Tjonneland A; Mortensen LM; Overvad K; Chang-Claude J; Rizzato C; Boeing H; Bueno-de-Mesquita HB; Siersema P; Peeters PH; Numans ME; Carneiro F; Licaj I; Freisling H; Sala N; González CA
    Int J Cancer; 2014 Jan; 134(1):92-101. PubMed ID: 23824692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of NOD1 and NOD2 genes polymorphisms with Helicobacter pylori related gastric cancer in a Chinese population.
    Wang P; Zhang L; Jiang JM; Ma D; Tao HX; Yuan SL; Wang YC; Wang LC; Liang H; Zhang ZS; Liu CJ
    World J Gastroenterol; 2012 May; 18(17):2112-20. PubMed ID: 22563200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional polymorphisms of CD14 and toll-like receptor 4 in Taiwanese Chinese with Helicobacter pylori-related gastric malignancies.
    Wu MS; Cheng TY; Shun CT; Lin MT; Chen LC; Lin JT
    Hepatogastroenterology; 2006; 53(71):807-10. PubMed ID: 17086894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Study between SNPs in MST1 and MST2 and H. pylori Infection as well as Noncardia Gastric Carcinogenesis.
    Ma L; Gao F; Dong W; Song Q; Jia Y
    Dig Dis; 2024; 42(3):230-239. PubMed ID: 38295774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
    Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
    J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer.
    Ma LC; Tian XY; Gao F; Dong WJ; Dang T; Jia YB
    BMC Gastroenterol; 2020 May; 20(1):155. PubMed ID: 32423384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in the Toll-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer.
    Castaño-Rodríguez N; Kaakoush NO; Pardo AL; Goh KL; Fock KM; Mitchell HM
    Hum Immunol; 2014 Aug; 75(8):808-15. PubMed ID: 24929142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation analysis in a follow-up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14.
    Companioni O; Bonet C; García N; Ramírez-Lázaro MJ; Lario S; Mendoza J; Adrados MM; Poves E; Espinosa L; Pozo-Kreilinger JJ; Ortega L; Bujanda L; Cosme A; Ferrández A; Muñoz G; Cuatrecasas M; Elizalde I; Andreu V; Paules MJ; Madrigal B; Barrio J; Berdasco M; Calvet X; Sanz-Anquela JM; Gisbert JP; González CA; Sala N;
    Int J Cancer; 2018 Dec; 143(11):2777-2786. PubMed ID: 30171605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Polymorphisms in Inflammatory and Other Regulators in Gastric Cancer: Risks and Clinical Consequences.
    Rudnicka K; Backert S; Chmiela M
    Curr Top Microbiol Immunol; 2019; 421():53-76. PubMed ID: 31123885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study.
    Palli D; Masala G; Del Giudice G; Plebani M; Basso D; Berti D; Numans ME; Ceroti M; Peeters PH; Bueno de Mesquita HB; Buchner FL; Clavel-Chapelon F; Boutron-Ruault MC; Krogh V; Saieva C; Vineis P; Panico S; Tumino R; Nyrén O; Simán H; Berglund G; Hallmans G; Sanchez MJ; Larrãnaga N; Barricarte A; Navarro C; Quiros JR; Key T; Allen N; Bingham S; Khaw KT; Boeing H; Weikert C; Linseisen J; Nagel G; Overvad K; Thomsen RW; Tjonneland A; Olsen A; Trichoupoulou A; Trichopoulos D; Arvaniti A; Pera G; Kaaks R; Jenab M; Ferrari P; Nesi G; Carneiro F; Riboli E; Gonzalez CA
    Int J Cancer; 2007 Feb; 120(4):859-67. PubMed ID: 17131317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori genotypes determine risk of non-cardia gastric cancer and intestinal- or diffuse-type GC in Ardabil: A very high-risk area in Northwestern Iran.
    Abdi E; Latifi-Navid S; Zahri S; Yazdanbod A; Safaralizadeh R
    Microb Pathog; 2017 Jun; 107():287-292. PubMed ID: 28390977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China.
    Limburg P; Qiao Y; Mark S; Wang G; Perez-Perez G; Blaser M; Wu Y; Zou X; Dong Z; Taylor P; Dawsey S
    J Natl Cancer Inst; 2001 Feb; 93(3):226-33. PubMed ID: 11158192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of TLR2, TLR4 and CD14 genetic polymorphisms in gastric carcinogenesis: a case-control study and meta-analysis.
    Castaño-Rodríguez N; Kaakoush NO; Goh KL; Fock KM; Mitchell HM
    PLoS One; 2013; 8(4):e60327. PubMed ID: 23565226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD1 and NOD2 Genetic Variants in Association with Risk of Gastric Cancer and Its Precursors in a Chinese Population.
    Li ZX; Wang YM; Tang FB; Zhang L; Zhang Y; Ma JL; Zhou T; You WC; Pan KF
    PLoS One; 2015; 10(5):e0124949. PubMed ID: 25933107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in genes related to bacterial lipopolysaccharide/peptidoglycan signaling and gastric precancerous lesions in a population at high risk for gastric cancer.
    Kato I; Canzian F; Plummer M; Franceschi S; van Doorn LJ; Vivas J; Lopez G; Lu Y; Gioia-Patricola L; Severson RK; Schwartz AG; Muñoz N
    Dig Dis Sci; 2007 Jan; 52(1):254-61. PubMed ID: 17171451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors.
    Hold GL; Rabkin CS; Chow WH; Smith MG; Gammon MD; Risch HA; Vaughan TL; McColl KE; Lissowska J; Zatonski W; Schoenberg JB; Blot WJ; Mowat NA; Fraumeni JF; El-Omar EM
    Gastroenterology; 2007 Mar; 132(3):905-12. PubMed ID: 17324405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of COX-2, HMLH1 and CDKN2A gene by promoter methylation in gastric cancer: relationship with histological subtype, tumor location and Helicobacter pylori genotype.
    Alves MK; Ferrasi AC; Lima VP; Ferreira MV; de Moura Campos Pardini MI; Rabenhorst SH
    Pathobiology; 2011; 78(5):266-76. PubMed ID: 21849808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CD14 promoter polymorphisms in Helicobacter pylori infection--related gastric carcinoma.
    Zhao D; Sun T; Zhang X; Guo Y; Yu D; Yang M; Tan W; Wang G; Lin D
    Clin Cancer Res; 2007 Apr; 13(8):2362-8. PubMed ID: 17438094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD14 promoter-159 polymorphism is associated with reduced risk of intestinal-type gastric cancer in a Japanese population.
    Tahara T; Shibata T; Hirata I; Nakano H; Arisawa T
    Dig Dis Sci; 2009 Jul; 54(7):1508-12. PubMed ID: 19326213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic association of gastric cancer with miRNA clusters including the cancer-related genes MIR29, MIR25, MIR93 and MIR106: results from the EPIC-EURGAST study.
    Espinosa-Parrilla Y; Muñoz X; Bonet C; Garcia N; Venceslá A; Yiannakouris N; Naccarati A; Sieri S; Panico S; Huerta JM; Barricarte A; Menéndez V; Sánchez-Cantalejo E; Dorronsoro M; Brennan P; Duarte-Salles T; B As Bueno-de-Mesquita H; Weiderpass E; Lund E; Clavel-Chapelon F; Boutron-Ruault MC; Racine A; Numans ME; Tumino R; Canzian F; Campa D; Sund M; Johansson M; Ohlsson B; Lindkvist B; Overvad K; Tjønneland A; Palli D; Travis RC; Khaw KT; Wareham N; Boeing H; Nesi G; Riboli E; Gonzalez CA; Sala N
    Int J Cancer; 2014 Nov; 135(9):2065-76. PubMed ID: 24643999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.